Pharvaris N : Corporate Presentation 2024
MarketScreener,
Corporate Presentation August 2024 Pioneering science for patient choice 1 Focused on unmet need in the treatment of hereditary…
Corporate Presentation August 2024 Pioneering science for patient choice 1 Focused on unmet need in the treatment of hereditary…
ZUG, Switzerland, July 30, 2020 /PRNewswire/ --, a clinical-stage company focused on the discovery and development of novel…
/PRNewswire/ -- Pharvaris, a clinical-stage company focused on the discovery and development of novel oral B2-receptor…
/PRNewswire/ -- Pharvaris, a clinical-stage company focused on the discovery and development of novel oral B2-receptor…